View in EDS

Toward a Therapy for Autism Spectrum Disorder: The Formyl Peptide Receptor 2 Agonist MR-39 Supports Synaptic Health in the BTBR Mouse and Features a Favorable Safety Profile.

Saved in:
Bibliographic Details
Title: Toward a Therapy for Autism Spectrum Disorder: The Formyl Peptide Receptor 2 Agonist MR-39 Supports Synaptic Health in the BTBR Mouse and Features a Favorable Safety Profile.
Authors: Vitone D; Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, via Orabona 4 70125, Bari, Italy., Francavilla F; Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, via Orabona 4 70125, Bari, Italy., Ferraro MG; Department of Molecular Medicine and Medical Biotechnology, School of Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy., Speranza L; Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Via Domenico Montesano 49 80131, Naples, Italy., Cristiano C; Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Via Domenico Montesano 49 80131, Naples, Italy., Arduino I; Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, via Orabona 4 70125, Bari, Italy., Lopedota AA; Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, via Orabona 4 70125, Bari, Italy., Rossignolo F; Aptuit Srl, an Evotec Company, Via A. Fleming, 4 37135, Verona, Italy., Fontana S; Aptuit Srl, an Evotec Company, Via A. Fleming, 4 37135, Verona, Italy., Lorenzin L; Department of Veterinary Medical Sciences (DIMEVET), and Interdepartmental Center for Industrial Research, Life Science and Health Technologies (CIRI-SdV), University of Bologna, Via Tolara di Sopra 50, 40064 Ozzano dell'Emilia (BO), Italy., Sannia M; Iret Foundation, Via Tolara di Sopra 41/E 40064, Ozzano Emilia (BO), Italy., Calzà L; Department of Pharmacy and Biotechnologies (FaBiT), and Health Technologies (CIRI-SdV), University of Bologna, Via Belmeloro 6 40126, Bologna, Italy., Denora N; Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, via Orabona 4 70125, Bari, Italy., Volpicelli F; Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Via Domenico Montesano 49 80131, Naples, Italy., Crispino M; Department of Biology, University of Naples Federico II, Via Cinthia 80126, Naples, Italy., Lacivita E; Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, via Orabona 4 70125, Bari, Italy., Leopoldo M; Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, via Orabona 4 70125, Bari, Italy.
Source: ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2026 Jun 25; Vol. 9 (7), pp. 1911-1926. Date of Electronic Publication: 2026 Jun 25 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101721411 Publication Model: eCollection Cited Medium: Internet ISSN: 2575-9108 (Electronic) Linking ISSN: 25759108 NLM ISO Abbreviation: ACS Pharmacol Transl Sci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2575-9108
DOI:10.1021/acsptsci.6c00164